Evaluation of the Safety and Effectiveness of BELKYRA® Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Postmarketing Surveillance Study in Korea

NCT03691415 · clinicaltrials.gov ↗

TERMINATED

Status

71

Enrollment

INDUSTRY

Sponsor class

Stopped Study discontinued due to business decisions.

Conditions

Submental Fullness

Interventions

DRUG: BELKYRA Inj.

Sponsor

Allergan